Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Prosurg's Opal goes on sale:

This article was originally published in Clinica

Executive Summary

Prosurg's Opal probe for the treatment of urological and gynaecological disorders is poised for worldwide distribution. The California-based company introduced its outpatient needle ablation electrosurgical device at the recent American Urological Association meeting in Orlando. The probe, which has already received 510(k) clearance from the US FDA, can deliver anaesthetic agents or biomaterials to the tissue prior to radio frequency energy treatment and is compatible with diagnostic endoscopes.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts